Epstein Secrets

tment fund 1MDB. In what the journal casts as a move to assuage shareholders Goldman said four executives: chief Executive David Solomon, President John Waldron, Chief Financial Officer Stephen Scherr and the head of Goldman's international business, Richard Gnodde will give up $31 million in pay this year.

ed, "Tonight, the FDA has now approved the first drug to treat COVID-19. Hospitalizations rising in 40 states, six now hitting record highs." ABC's Matt Gutman added that FDA's announcement is "basically the gold seal of approval. ... It means that the agency recognizes that remdesivir is relatively safe to

tment fund 1MDB. In what the journal casts as a move to assuage shareholders Goldman said four executives: chief Executive David Solomon, President John Waldron, Chief Financial Officer Stephen Scherr and the head of Goldman's international business, Richard Gnodde will give up $31 million in pay this year.

ted, "Tonight, the FDA has now approved the first drug to treat COVID-19. Hospitalizations rising in 40 states, six now hitting record highs." ABC's Matt Gutman added that FDA's announcement is "basically the gold seal of approval.... It means that the agency recognizes that remdesivir is relatively safe to

stment fund 1MDB. In what the journal casts as a move to assuage shareholders Goldman said four executives: chief Executive David Solomon, President John Waldron, Chief Financial Officer Stephen Scherr and the head of Goldman's international business, Richard Gnodde will give up $31 million in pay this year.

ed, "Tonight, the FDA has now approved the first drug to treat COVID-19. Hospitalizations rising in 40 states, six now hitting record highs." ABC's Matt Gutman added that FDA's announcement is "basically the gold seal of approval. ... It means that the agency recognizes that remdesivir is relatively safe to